Norepinephrine is not required for reduction of feeding induced by cholecystokinin

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Cannon, C Matson ^a   Palmiter, R D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cholecystokinin 8; Dopamine hydroxylase; Knockout mice; Norepinephrine

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; NORADRENALIN; DOPAMINE BETA MONOOXYGENASE; PEPTIDE FRAGMENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; APPETITE; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; MALE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SATIETY; VAGUS NERVE; ANIMAL; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECT; FEEDING BEHAVIOR; FEMALE; FOOD DEPRIVATION; GENE DELETION; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PSYCHOPHYSIOLOGY; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; CHOLECYSTOKININ; DOPAMINE BETA-HYDROXYLASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEEDING BEHAVIOR; FEMALE; FOOD DEPRIVATION; GENE DELETION; MALE; MICE; MICE, KNOCKOUT; NOREPINEPHRINE; PEPTIDE FRAGMENTS; SATIETY RESPONSE; WEIGHT GAIN; WEIGHT LOSS;

EID: 0038515769     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00689.2002     Document Type: Article

References (54)

1. Barrachina MD, Martinez V, Wang L, Wei JY, and Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci USA 94: 10455-10460, 1997.
2. Bednar I, Carrer H, Qureshi GA, and Sodersten P. Dopamine D1 or D2 antagonists enhance inhibition of consummatory ingestive behavior by CCK-8. Am J Physiol Regul Integr Comp Physiol 269: R896-R903, 1995.
3. Bednar I, Forsberg G, Linden A, Qureshi G, and Sodersten P. Involvement of dopamine in inhibition of food intake by cholecystokinin octapeptide in male rats. J Neuroendocrinol 3: 491-496, 1991.
4. Bednar I, Qureshi G, and Sodersten P. A comparison between the effect of cholecystokinin octapeptide and apomorphine on ingestion of intraorally administered sucrose in male rats. J Neuroendocrinol 4: 727-734, 1992.
5. Bednar I, Qureshi G, and Sodersten P. Evidence that release of dopamine in the brain is involved in the inhibitory effect of cholecystokinin octapeptide on ingestion of intraorally infused sucrose in male rats. J Neuroendocrinol 4: 735-741, 1992.
6. Booth DA. Localization of the adrenergic feeding system in the rat diencephalon. Science 158: 515-517, 1967.
7. Booth DA. Mechanism of action of norepinephrine in eliciting an eating response on injection into the rat hypothalamus. J Pharmacol Exp Ther 160: 336-348, 1968.
8. Broberger C, Holmberg K, Kuhar MJ, and Hokfelt T. Cocaine-and amphetamine-regulated transcript in the rat vagus nerve: a putative mediator of cholecystokinin-induced satiety. Proc Natl Acad Sci USA 96: 13506-13511, 1999.
9. Day HE, McKnight AT, Poat JA, and Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 33: 719-727, 1994.
10. Esfahani N, Bednar I, Qureshi GA, and Sodersten P. Inhibition of serotonin synthesis attenuates inhibition of ingestive behavior by CCK-8. Pharmacol Biochem Behav 51: 9-12, 1995.
11. Figlewicz DP, Sipols AJ, Seeley RJ, Chavez M, Woods SC, and Porte D Jr. Intraventricular insulin enhances the meal-suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon. Behav Neurosci 109: 567-569, 1995.
12. Gibbs J, Young R, and Smith G. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495, 1973.
13. Glowinski J. Some characteristics of the "functional" and "main storage" compartments in central catecholaminergic neurons. Brain Res 62: 489-493, 1973.
14. Glowinski J. Some new facts about synthesis, storage and release processes of monoamines in the central nervous system. In: Perspectives in Neuropharmacology: A Tribute to Julius Axelrod, edited by Snyder S. Toronto: Oxford Univ. Press, 1972, p. 349-403.
15. Grossman SP. Direct cholinergic and adrenergic stimulation of hypothalamic mechanisms. Am J Physiol 202: 872, 1962.
16. Grossman SP. Eating or drinking elicited by direct adrenergic or cholinergic stimulation of hypothalamus. Obes Res 5: 291-293, 1997.
17. Kadar T, Varszegi M, Sudakov SK, Penke B, and Telegdy G. Changes in brain monoamine levels of rats during cholecystokinin octapeptide-induced suppression of feeding. Pharmacol Biochem Behav 21: 339-344, 1984.
18. Kaneyuki T, Morimasa T, and Shohmori T. Action of peripherally administered cholecystokinin on monoaminergic and GABAergic neurons in the rat brain. Acta Med Okayama 43: 153-159, 1989.
19. Kissileff HR, Pi-Sunyer FX, Thornton J, and Smith GP. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 34: 154-160, 1981.
20. Kopin AS, Mathes WF, McBride EW, Nguyen M, Al-Haider W, Schmitz F, Bonner-Weir S, Kanarek R, and Beinborn M. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 103: 383-391, 1999.
21. Leibowitz SF. Hypothalamic beta-adrenergic "satiety" system antagonizes an alpha-adrenergic "hunger" system in the rat. Nature 226: 963-964, 1970.
22. Leibowitz SF. Ingestion in the satiated rat: role of alpha and beta receptors in mediating effects of hypothalamic adrenergic stimulation. Physiol Behav 14: 743-754, 1975.
23. Leibowitz SF. Reciprocal hunger-regulating circuits involving alpha- and beta-adrenergic receptors located, respectively, in the ventromedial and lateral hypothalamus. Proc Natl Acad Sci USA 67: 1063-1070, 1970.
24. Luckman S. Fos-like immunoreactivity in the brainstem of the rat following peripheral administration of cholecystokinin. J Neuroendocrinol 4: 149-152, 1992.
25. Luckman SM, Hamamura M, Antonijevic I, Dye S, and Leng G. Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion. Br J Pharmacol 110: 378-384, 1993.
26. 14C]norepinephrine from the rat hypothalamus during feeding. Am J Physiol 229: 1547-1555, 1975.
27. Matson CA, Reid DF, Cannon TA, and Ritter RC. Cholecystokinin and leptin act synergistically to reduce body weight. Am J Physiol Regul Integr Comp Physiol 278: R882-R890, 2000.
28. Matson CA, Reid DF, and Ritter RC. Daily CCK injection enhances reduction of body weight by chronic intracerebroventricular leptin infusion. Am J Physiol Regul Integr Comp Physiol 282: R1368-R1373, 2002.
29. Matson CA and Ritter RC. Long-term CCK-leptin synergy suggests a role for CCK in the regulation of body weight. Am J Physiol Regul Integr Comp Physiol 276: R1038-R1045, 1999.
30. Matson CA, Wiater MF, Kuijper JL, and Weigle DS. Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake. Peptides 18: 1275-1278, 1997.
31. McCaleb ML and Myers RD. Cholecystokinin acts on the hypothalamic "noradrenergic system" involved in feeding. Peptides 1: 47-49, 1980.
32. McCaleb ML, Myers RD, Singer G, and Willis G. Hypothalamic norepinephrine in the rat during feeding and push-pull perfusion with glucose, 2-DG, or insulin. Am J Physiol Regul Integr Comp Physiol 236: R312-R321, 1979.
33. McMinn JE, Sindelar DK, Havel PJ, and Schwartz MW. Leptin deficiency induced by fasting impairs the satiety response to cholecystokinin. Endocrinology 141: 4442-4448, 2000.
34. McQueen A, Armstrong S, and Singer G. Noradrenergic feeding system in monkey hypothalamus is altered by localized perfusion of glucose, insulin, 2-DG and eating. Pharmacol Biochem Behav 5: 491-494, 1976.
35. Monnikes H, Lauer G, and Arnold R. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res 770: 277-288, 1997.
36. Myers RD. Peptide-catecholamine interaction: feeding and satiety. Psychopharmacol Bull 21: 406-411, 1985.
37. Myers RD and McCaleb ML. Peripheral and intrahypothalamic cholecystokinin act on the noradrenergic "feeding circuit" in the rat's diencephalon. Neuroscience 6: 645-655, 1981.
38. Onaka T, Luckman SM, Antonijevic I, Palmer JR, and Leng G. Involvement of the noradrenergic afferents from the nucleus tractus solitarii to the supraoptic nucleus in oxytocin release after peripheral cholecystokinin octapeptide in the rat. Neuroscience 66: 403-412, 1995.
39. Palkovits M, Brownstein M, Saavedra JM, and Axelrod J. Norepinephrine and dopamine content of hypothalamic nuclei of the rat. Brain Res 77: 137-149, 1974.
40. Perrone MH. Biochemical evidence that L-glutamate is a neurotransmitter of primary vagal afferent nerve fibers. Brain Res 230: 283-293, 1981.
41. Poeschla B, Gibbs J, Simansky KJ, Greenberg D, and Smith GP. Cholecystokinin-induced satiety depends on activation of 5-HT1C receptors. Am J Physiol Regul Integr Comp Physiol 264: R62-R64, 1993.
42. Poeschla B, Gibbs J, Simansky KJ, and Smith GP. The 5-HT1A agonist 8-OH-DPAT attenuates the satiating action of cholecystokinin. Pharmacol Biochem Behav 42: 541-543, 1992.
43. Riedy CA, Chavez M, Figlewicz DP, and Woods SC. Central insulin enhances sensitivity to cholecystokinin. Physiol Behav 58: 755-760, 1995.
44. Ritter R. Noradrenergic Control of Spontaneous Meal Size in the Rat (Thesis). University of Pennsylvania, 1974.
45. Ritter RC, Covasa M, and Matson CA. Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight. Neuropeptides 33: 387-399, 1999.
46. Ritter RC and Epstein AN. Control of meal size by central noradrenergic action. Proc Natl Acad Sci USA 72: 3740-3743, 1975.
47. Smith GP, Jerome C, Cushin BJ, Eterno R, and Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213: 1036-1037, 1981.
48. Stallone D, Nicolaidis S, and Gibbs J. Cholecystokinin-induced anorexia depends on serotoninergic function. Am J Physiol Regul Integr Comp Physiol 256: R1138-R1141, 1989.
49. Sykes RM, Spyer KM, and Izzo PN. Demonstration of glutamate immunoreactivity in vagal sensory afferents in the nucleus tractus solitarius of the rat. Brain Res 762: 1-11, 1997.
50. Thierry AM, Blanc G, and Glowinski J. Further evidence for the heterogeneous storage of noradrenaline in central noradrenergic terminals. Naunyn Schmiedebergs Arch Pharmacol 279: 255-266, 1973.
51. Thomas SA, Marck BT, Palmiter RD, and Matsumoto AM. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70: 2468-2476, 1998.
52. Thomas SA, Matsumoto AM, and Palmiter RD. Noradrenaline is essential for mouse fetal development. Nature 374: 643-646, 1995.
53. Thomas SA and Palmiter RD. Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline. Nature 387: 94-97, 1997.
54. West DB, Fey D, and Woods SC. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol Regul Integr Comp Physiol 246: R776-R787, 1984.